Clinical Trial: Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07592585) titled 'Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis' on May 12.

Brief Summary: A multicenter, randomized, double-blind, vehicle controlled phase III clinical study to evaluate the efficacy and safety of VC005 in adults and adolescents with mild to moderate atopic dermatitis

Study Start Date: May 30

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis

Intervention: DRUG: VC005

VC005 Placebo group with Local topical application

DRUG: VC005 Placebo

VC005 Placebo group with Local topical application

Recruitment Status: NOT_YET_RECRUITING

Spon...